Stryker Hip Lawsuit 2026: the $1.43 Billion Settlement, Who Missed It & Who Can Still File
In November 2014, Stryker agreed to pay about $1.43 billion to resolve thousands of lawsuits over its recalled Rejuvenate and ABG II hip implants, with a $300,000 base award for revised patients. If your Stryker hip failed — or is failing now — this 2026 guide explains what went wrong, who the settlement covered, and which options remain open.
For video explainers on how medical-device lawsuits work, see the Problem Solved channel on YouTube.
What Went Wrong With These Hips
Fretting is the microscopic wear that occurs when two metal surfaces rub against each other; corrosion is the chemical breakdown of that metal inside the body. Metallosis is the poisoning of surrounding tissue by metal debris shed from an implant, and adverse local tissue reaction (ALTR) is the umbrella term for the tissue destruction, fluid collections, and bone damage that follow. Stryker's Rejuvenate and ABG II modular-neck hip stems were designed to be customizable — surgeons could mix and match components to fit each patient's anatomy. The modular neck junctions, however, corroded in the body, releasing cobalt and chromium particles and setting off exactly the cascade described above.
Key Facts
- July 2012: Stryker voluntarily recalled the Rejuvenate and ABG II modular-neck hip stems after reports of fretting and corrosion at the modular neck junction.
- About $1.43 billion: the November 3, 2014 settlement resolving roughly 4,000 revision cases, with a base award of $300,000 per patient who had the device surgically removed before the cutoff.
- 20,000+ lawsuits: the total number of claims filed against Stryker over these implants, consolidated in federal MDL-2441 and New Jersey state court.
- 2016 recall: Stryker separately recalled the LFIT V40 femoral head for taper lock failure — a different defect producing the same metal-debris injuries.
- TMZF alloy: the proprietary titanium-molybdenum-zinc-iron blend Stryker said would reduce corrosion — post-market data showed it did not.
The 2012 Recall
In July 2012, Stryker issued a nationwide voluntary recall of the Rejuvenate and ABG II modular-neck hip stems after identifying an increased risk of fretting and corrosion at the modular neck junction. The company had marketed the TMZF alloy as corrosion-resistant; post-market experience proved otherwise. Patients began reporting pain, swelling, loosening of the implant, and in many cases the need for a second operation — revision surgery — to remove the failing device. As complications accumulated, thousands of lawsuits were filed in state and federal courts.
The $1.43 Billion Settlement
On November 3, 2014, Stryker agreed to the global settlement that resolved the Rejuvenate and ABG II litigation: about $1.43 billion, covering approximately 4,000 cases where patients had undergone revision surgery on or before November 2, 2014. The program paid a base award of $300,000 per case, with additional amounts for patients who suffered extraordinary injuries such as multiple surgeries. Compensation varies widely by case, and most settlements are confidential, but the documented terms of this named settlement program remain the benchmark every later Stryker hip case is measured against.
The LFIT V40 Recall of 2016
The Rejuvenate and ABG II stems were not Stryker's only hip problem. In 2016 the company recalled the LFIT V40 femoral head after a high rate of taper lock failure — the locking mechanism between the femoral head and stem loosened, allowing the same fretting and corrosion to release metal ions into patients' bodies. Claims over the LFIT V40 ran on a separate track from the 2014 settlement, and injured patients have pursued them independently.
Signs Your Stryker Hip May Be Failing
The complications documented in the litigation read like a checklist patients still report today: persistent pain and swelling around the hip, a loosening sensation or instability, unexplained fatigue or neurological symptoms consistent with metal ion exposure, and fluid collections visible on imaging. None of these symptoms proves a defect — only medical testing can do that — but every one of them was common in the cases that drove the $1.43 billion settlement. If you still have one of these implants, blood tests for cobalt and chromium levels and imaging for tissue damage are the standard medical follow-up.
Who Can Still File in 2026
The 2014 settlement closed only cases that qualified under its terms — patients revised before the cutoff. People who developed late-onset complications, who were never included in the original program, or who received the LFIT V40 head may still have active legal options in 2026, though the clock is the real issue: statutes of limitation and repose differ by state, and some have already closed for 2012-era implants. Three practical steps apply now: confirm which Stryker components you received (the operative report names them), document any failure medically, and speak with a lawyer before contacting Stryker's hotline or Broadspire — you could sign away rights to future compensation. The same device-litigation playbook that built the DePuy hip implant cases and the metal-on-metal hip cases applies to Stryker — and Exactech implant claims show how 2026 courts still treat defective packaging and materials cases.
Who Benefits From This — and Who Does Not
Who benefits:
- Patients revised on or before November 2, 2014 — How: the November 2014 settlement program covered them, with a documented base award of $300,000 per case for patients who had the recalled device surgically removed before the cutoff
- Patients with late-onset complications or an LFIT V40 device — How: if you missed that program, you may still have individual legal options in 2026, subject to your state's filing deadlines
- Patients with extraordinary injuries — How: the program paid enhanced awards for extraordinary injuries such as multiple revision surgeries
Who does not benefit:
- Patients who expect the 2014 settlement program to still be open — it applied to patients revised on or before November 2, 2014 — later revisions fall under individual options, not that program
- Patients with any Stryker hip at all — the recalls covered specific model lines — the Rejuvenate and ABG II modular-neck stems recalled in July 2012 and the LFIT V40 femoral head in 2016 — not every Stryker hip ever implanted
- Patients who deal with Stryker's hotline without advice — lawyers warn that calls to Stryker's hotline or Broadspire can involve signing away future rights, and that the base payout may be less than what a case is worth
Related reading: Beovu Eye Injection Lawsuit 2026: Vision Loss Claims, Who Qualifies & How to File
Frequently Asked Questions
Was my Stryker hip implant recalled?
It may have been. Stryker recalled the Rejuvenate and ABG II modular-neck hip stems in July 2012 and the LFIT V40 femoral head in 2016. Your operative report or your surgeon's office can confirm the exact components; the recall covered specific model lines, not every Stryker hip ever implanted.
Can I still join the Stryker settlement?
The $1.43 billion settlement program from November 2014 applied to patients revised on or before November 2, 2014. If you missed that program — because of late-onset complications, a later revision, or an LFIT V40 device — you may still have individual legal options in 2026, subject to your state's filing deadlines.
What was the base payment in the Stryker settlement?
The documented program paid a base award of $300,000 per case to patients who had the recalled device surgically removed before the cutoff, with enhanced awards for extraordinary injuries such as multiple revision surgeries.
Do I need a lawyer, or can I deal with Stryker directly?
Stryker says you do not need an attorney, but lawyers who handle these cases warn that the base payout may be less than what your case is worth — and that calls to Stryker's hotline or Broadspire can involve signing away future rights. Most patients in this litigation were represented.
Who benefits most from the Stryker guide — and who does it not help?
It helps most patients who had a recalled Rejuvenate, ABG II or LFIT V40 device: those revised on or before November 2, 2014 fell under the $1.43 billion settlement program with a $300,000 base award, and late-onset or LFIT V40 patients may still have individual options in 2026. It does not help patients with a non-recalled Stryker model, or anyone who expects the 2014 program to still be open for later revisions.
How do I start a Stryker claim review?
Confirm your exact components first: your operative report or your surgeon's office can confirm whether you had a recalled Rejuvenate, ABG II or LFIT V40 device, since the recalls covered specific model lines. Then check your state's filing deadlines for individual options in 2026, and get legal review before signing anything after calls to Stryker's hotline or Broadspire — lawyers warn those contacts can involve signing away future rights.
This article provides general information about Stryker hip implant litigation and is not legal or medical advice. Statutes of limitation differ by state; consult a qualified attorney about your situation.